BETS - KPTI PRSO and NERV among mid-day movers
2024-02-05 13:05:53 ET
More on Mid-day movers $ stocks.
- Karyopharm: Approaching The Bottom Ahead Of Earnings And Topline Data (Rating Upgrade)
- Karyopharm Therapeutics: Promising Potential With 3 Ongoing Phase 3 Studies But Risky
- Peraso Inc. (PRSO) Q3 2023 Earnings Call Transcript
- Karyopharm expects FY total revenue to be ~$145.9 million
- Peraso stock plummets on 1-for-40 reverse stock split